Advanced search

200 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Moderna : 2024 Proxy Statement	17/04	PU
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences	09/04	AQ
Moderna, Inc. prepares for the post-Covid era	25/03
Moderna Chief Executive Officer Stephane Bancel Elected to National Academy of Engineering	08/02	AQ
Transcript : Alexandria Real Estate Equities, Inc., Q4 2023 Earnings Call, Jan 30, 2024	31/01
Transcript : Alexandria Real Estate Equities, Inc. - Analyst/Investor Day	29/11
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics	21/11	PR
Moderna Chairman Afeyan on Industry Outlook, Strategy, AI	09/11	MT
Moderna, Inc. : melts like snow in the sun	07/11
Flagship Pioneering Launches Pioneering Intelligence	01/11	PR
Alexandria Real Estate Equities, Inc.'s One-of-a-Kind, Essential Labspace Platform Empowers the Integration and Enhancement of Biological Discoveries Enabled by AI to Widen the Opportunities for and Accelerate the Development of Novel Medicines	27/23/27	PR
Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines' $273 mln fundraise	14/23/14	RE
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer	11/23/11	PR
Omega Therapeutics, Inc. Announces Board Changes	29/23/29	CI
Omega Therapeutics Announces Updates to its Board of Directors	29/23/29	GL
Omega Therapeutics, Inc. Appoints Chris Schade as Chairman of the Board	29/23/29	CI
Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines	15/23/15	AQ
ALLTRNA ANNOUNCES SERIES B RAISE OF $109 MILLION TO ADVANCE TRNA MEDICINES FOR STOP CODON DISEASE	10/23/10	AQ
Flagship Pioneering Announces Appointment of Rupert Vessey as Chief Scientist	14/23/14	AQ
Omega Therapeutics Appoints Chris Schade to its Board of Directors	12/23/12	GL
Flagship Pioneering Unveils Empress Therapeutics to Revolutionize Drug Discovery by Applying the Power of Genetics to Identify Small Molecule Drugs	21/23/21	PR
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry	16/23/16	PR
Axcella Health : 10K HTML Q4 22	30/23/30	PU
RUBIUS THERAPEUTICS, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K)	03/22/03	AQ
Transcript : Omega Therapeutics, Inc. Presents at H.C. Wainwright 24th Annual Global Investment Conference, Sep-12-2022 10:00 AM	12/22/12
Omega Therapeutics Announces Appointment of Rainer Boehm to its Board of Directors	01/22/01	PR
Evelo Biosciences Announces Succession Plan	11/22/11	GL
OMEGA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	10/22/10	AQ
Rubius Therapeutics : Appoints Noubar Afeyan as Chairman of its Board of Directors - Form 8-K	24/22/24	PU
RUBIUS THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	24/22/24	AQ
Rubius Therapeutics Appoints Noubar Afeyan as Chairman of its Board of Directors	24/22/24	GL
Rubius Therapeutics Appoints Noubar Afeyan as Chairman of its Board of Directors	24/22/24	CI
MODERNA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	04/22/04	AQ
Moderna to open vaccine factory in Canada, its first abroad	30/22/30	AQ
Transcript : Moderna, Inc. - Shareholder/Analyst Call	28/22/28
Abbvie Vice Chairman Severino Departs for Flagship Pioneering	13/22/13	DJ
Moderna to Set Up Sh60bn Covid Vaccine Plant in Kenya, the First in Africa	08/22/08	AQ
Moderna : Announces Memorandum of Understanding with the Government of the Republic of Kenya to Establish its First mRNA Manufacturing Facility in Africa	07/22/07	PU
Moderna : Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29 Full year 2021 revenues of $18.5 billion; GAAP net-income of $12.2 billion and GAAP diluted EPS of $28.29 Moderna increased its 2022 signed advance purchase agreements to approximately $19 billion, with additional signed options of approximately $3 billion; numerous discussions ongoing with governments for the fall of 2022 and 2023 Moderna received full U.S. FDA approval for COVID-19 vaccine, Spikevax	24/22/24	PU
Moderna : Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates	24/22/24	PU
General Electric : GE Digital’s Colin Parris Elected as a Member of the National Academy of Engineers (NAE)	11/22/11	PU
Flagship Pioneering Announces Appointment of Tom DiLenge as Senior Partner, Global Public Policy, Regulatory & Governmental Strategy	25/22/25	PR
Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Test	07/21/07	PR
Omicron variant found in nearly one-third of U.S. states	06/21/06	RE
Omicron variant found in nearly one-third of U.S. states	05/21/05	RE
Generate Biomedicines Announces First External Equity Raise of $370 Million to Advance Its Drug Generation Platform	18/21/18	BU
Flagship Pioneering Announces Appointment of Justine Levin-Allerhand as Senior Partner, Corporate Development	15/21/15	PR
Flagship Pioneering Launches Alltrna to Unlock Transfer RNA Biology and Treat Thousands of Diseases with a Single tRNA Medicine	09/21/09	PR
Pioneering Medicines, An Initiative Of Flagship Pioneering, Establishes First-Of-Its-Kind Partnership With The Cystic Fibrosis Foundation To Develop Breakthrough Treatments For CF	03/21/03	PR
Africa Looks to Kick-Start Covid Vaccine Production [analysis]	29/21/29	AQ

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW